Steven C. Almo, Ph.D.
Chief Innovation Officer
Steven C. Almo, Ph.D., is Professor and Chair of the Department of Biochemistry and Professor of Physiology & Biophysics at Albert Einstein College of Medicine. He holds the Wollowick Family Foundation Chair in Immunology and is the Director of Einstein's Macromolecular Therapeutics Development Facility, which leverages automation and robotics to accelerate the development of protein-based therapeutics. An internationally recognized leader in the field of structural biology and author of over 300 papers, Dr. Almo has made significant contributions to our understanding of immunology, including high resolution structural and biochemical characterization of the CTLA-4 and PD-1 immune checkpoint proteins and their ligands. His lab has been at the center of advancing high-throughput methods for expressing proteins, determining their structure, and interrogating their function, as well as developing innovative receptor-ligand de-orphaning platforms. Dr. Almo is a member of the American Society for Cell Biology and the American Crystallographic Association. Dr. Almo is also a Co-Founder and Chair of the Scientific Advisory Board of Cue Biopharma.